Erik C. Emerson - 16 Jan 2024 Form 4 Insider Report for Odyssey Health, Inc. (ODYY)

Role
Chief Commerical Officer
Signature
/s/ Christine M. Farrell, as Attorney-in-Fact for Erik C. Emerson
Issuer symbol
ODYY
Transactions as of
16 Jan 2024
Transactions value $
$3,188
Form type
4
Filing time
18 Jan 2024, 17:10:09 UTC
Previous filing
02 Jan 2024
Next filing
08 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ODYY Stock Option (Right to Buy) Award $3.19K +37.5K $0.09 37.5K 16 Jan 2024 Common Stock 37.5K $0.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The non-qualified stock options are granted outside the Amended and Restated 2021 Omnibus Stock Incentive Plan, vesting immediately and the exercise price is the closing price on the date of the grant, January 16, 2024.